semaglutide poisoning approval boosts GLP-1 poison center reports Texas poison centers see a

The FDA has authorised Ozempic, a once-weekly injectable, for treating diabetes but not for weight reduction

it can ruin a lot of clothes

The oral options start lower but can increase as dosage escalates

Zepbound raked in $4.3 billion in the fourth quarter, which was up 123% year over year and an increase from $3.6 billion in the third quarter and, Yee noted, the drug continues to show robust growth despite compounded injectable GLP-1 Wegovy. Lilly is projecting 2026 sales to come in at between $80 billion and $83 billion, Fierce Pharma reported this week

This gap has presumably resulted in the four times difference in prescription rates between White and Black patients